Inducible BRAF Suppression Models for Melanoma Tumorigenesis

Methods in Enzymology

Volumn 439, Issue , 2008, Pages 25-38

  Hoeflich, Klaus P ^a   Jaiswal, Bijay ^a   Davis, David P ^a   Seshagiri, Somasekar ^a  

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; GLUTAMIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; SHORT HAIRPIN RNA; VALINE;

AMINO ACID SUBSTITUTION; CANCER CELL CULTURE; CARCINOGENESIS; CELL PROLIFERATION; CELL SURVIVAL; ENZYME ACTIVATION; ENZYME REPRESSION; MELANOMA; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SOMATIC MUTATION; TUMOR GROWTH; XENOGRAFT; ANIMAL; ARTICLE; GENE VECTOR; GENETICS; HUMAN; METASTASIS; MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; GENETIC VECTORS; HUMANS; MELANOMA; MICE; NEOPLASM METASTASIS; PROTO-ONCOGENE PROTEINS B-RAF;

EID: 45549099983     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(07)00403-X     Document Type: Review

References (19)

1. Allen L.F., Sebolt-Leopold J., and Meyer M.B. CI-1040 (PD184352), a targeted signal transduction inhibitor of MEK (MAPKK). Semin. Oncol. 30 (2003) 105-116
2. Brummelkamp T.R., Bernards R., and Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 296 (2002) 550-553
3. Collisson E.A., Kleer C., Wu M., De A., Gambhir S.S., Merajver S.D., and Kolodney M.S. Atorvastatin prevents RhoC isoprenylation, invasion, and metastasis in human melanoma cells. Mol. Cancer Ther. 2 (2003) 941-948
4. Davies H., Bignell G.R., Cox C., Stephens P., Edkins S., Clegg S., Teague J., Woffendin H., Garnett M.J., Bottomley W., Davis N., Dicks E., et al. Mutations of the BRAF gene in human cancer. Nature 417 (2002) 949-954
5. Dhomen N., and Marais R. New insight into BRAF mutations in cancer. Curr. Opin. Genet. Dev. 17 (2007) 31-39
6. Downward J. Targeting RAS signalling pathways in cancer therapy. Nat. Rev. Cancer 3 (2003) 11-22
7. Gray D.C., Hoeflich K.P., Peng L., Gu Z., Gogineni A., Murray L.J., Eby M., Kljavin N., Seshagiri S., Cole M.J., and Davis D.P. pHUSH: A single vector system for conditional gene expression. BMC Biotechnol. 7 (2007) 61
8. Gray-Schopfer V., Wellbrock C., and Marais R. Melanoma biology and new targeted therapy. Nature 445 (2007) 851-857
9. Hillen W., Schollmeier K., and Gatz C. Control of expression of the Tn10-encoded tetracycline resistance operon. II. Interaction of RNA polymerase and TET repressor with the tet operon regulatory region. J. Mol. Biol. 172 (1984) 185-201
10. Hoeflich K.P., Gray D.C., Eby M.T., Tien J.Y., Wong L., Bower J., Gogineni A., Zha J., Cole M.J., Stern H.M., Murray L.J., Davis D.P., et al. Oncogenic BRAF is required for tumor growth and maintenance in melanoma models. Cancer Res. 66 (2006) 999-1006
11. Mercer K., Giblett S., Green S., Lloyd D., DaRocha Dias S., Plumb M., Marais R., and Pritchard C. Expression of endogenous oncogenic V600EB-raf induces proliferation and developmental defects in mice and transformation of primary fibroblasts. Cancer Res. 65 (2005) 11493-11500
12. Myslinski E., Ame J.C., Krol A., and Carbon P. An unusually compact external promoter for RNA polymerase III transcription of the human H1RNA gene. Nucleic Acids Res. 29 (2001) 2502-2509
13. Pollock P.M., Harper U.L., Hansen K.S., Yudt L.M., Stark M., Robbins C.M., Moses T.Y., Hostetter G., Wagner U., Kakareka J., Salem G., Pohida T., et al. High frequency of BRAF mutations in nevi. Nat. Genet. 33 (2003) 19-20
14. Ray P., De A., Min J.J., Tsien R.Y., and Gambhir S.S. Imaging tri-fusion multimodality reporter gene expression in living subjects. Cancer Res. 64 (2004) 1323-1330
15. Wan P.T., Garnett M.J., Roe S.M., Lee S., Niculescu-Duvaz D., Good V.M., Jones C.M., Marshall C.J., Springer C.J., Barford D., and Marais R. Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. Cell 116 (2004) 855-867
16. Wellbrock C., Karasarides M., and Marais R. The RAF proteins take centre stage. Nat. Rev. Mol. Cell. Biol. 5 (2004) 875-885
17. Wellbrock C., Ogilvie L., Hedley D., Karasarides M., Martin J., Niculescu-Duvaz D., Springer C.J., and Marais R. V599EB-RAF is an oncogene in melanocytes. Cancer Res. 64 (2004) 2338-2342
18. Yao F., Svensjö T., Winkler T., Lu M., Eriksson C., and Eriksson E. Tetracycline repressor, tetR, rather than the tetR-mammalian cell transcription factor fusion derivatives, regulates inducible gene expression in mammalian cells. Hum. Gene Ther. 9 (1998) 1939-1950
19. Yazdi A.S., Palmedo G., Flaig M.J., Puchta U., Reckwerth A., Rutten A., Mentzel T., Hugel H., Hantschke M., Schmid-Wendtner M.H., Kutzner H., and Sander C.A. Mutations of the BRAF gene in benign and malignant melanocytic lesions. J. Invest. Dermatol. 121 (2003) 1160-1162